Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Revenue

Ningxia Zhongke Biotechnology had revenue of 111.76M CNY in the quarter ending September 30, 2025, with 57.34% growth. This brings the company's revenue in the last twelve months to 488.14M, up 61.85% year-over-year. In the year 2024, Ningxia Zhongke Biotechnology had annual revenue of 345.32M with 20.87% growth.

• Revenue (ttm): 488.14M
• Revenue Growth: +61.85%
• P/S Ratio: 5.26
• Revenue / Employee: 585.30K
• Employees: 834
• Market Cap: 2.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	345.32M	59.63M	20.87%
Dec 31, 2023	285.69M	-395.44M	-58.06%
Dec 31, 2022	681.13M	432.42M	173.86%
Dec 31, 2021	248.72M	129.60M	108.80%
Dec 31, 2020	119.11M	-146.64M	-55.18%